LXEO$3.09+0.82%
Lexeo Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$253.24M
Float & O/S:
Inst Own:
DilutionScan read 52 of Lexeo Therapeutics, Inc.'s SEC filings and found 3 warrant series, 1 ATM program, 4 shelf registrations and 4 completed offerings on file for LXEO. The latest dilution event on file is ATM sales on Oct 29, 2026. Analysis updated Oct 31, 2026.
